Related Experiment Video
Updated: Jul 23, 2025
06:28
Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
569
Trials Informing Back Pain Guidelines Underreport Key Sociodemographic Data
Journal of Health Care for the Poor and Underserved
|July 19, 2023
Summary
Clinical trials for low back pain (LBP) lack comprehensive sociodemographic data. Reporting on race, ethnicity, education, and income is inconsistent, hindering diverse representation in LBP research.
Area of Science:
- Clinical Research
- Health Services Research
- Pain Management
Background:
- Sociodemographic factors significantly influence low back pain (LBP) outcomes.
- Diverse participant representation is crucial for appraising the generalizability of clinical trial findings.
- Existing LBP treatment guidelines rely on clinical trials with potentially limited sociodemographic reporting.
Purpose of the Study:
- To evaluate the reporting of participant sociodemographic variables in clinical trials that inform the American College of Physicians (ACP) guidelines for LBP treatment.
- To identify gaps in sociodemographic data collection and reporting within key LBP clinical trials.
Main Methods:
- A systematic review of clinical trials was conducted.
- Trials supporting recommended interventions in the ACP guidelines for LBP were analyzed for the reporting of participant sociodemographic data.
- Data on race, ethnicity, education, income, employment, insurance, marital status, religion, and residence were extracted.
Main Results:
- Out of 116 reviewed trials, only 34 reported on participant race and/or ethnicity.
- Reporting varied significantly for other sociodemographic variables: education (24 trials), income (10 trials), employment (31 trials), insurance (3 trials), marital status (16 trials), and religion (2 trials).
- Language comprehension was the most common exclusion criterion, highlighting potential barriers to diverse participation.
Conclusions:
- Clinical trials informing ACP guidelines for LBP treatment provide insufficient sociodemographic data.
- There is a critical need for LBP intervention investigators to recruit diverse participants.
- Comprehensive reporting of sociodemographic data is essential for understanding treatment efficacy across different populations.
Related Concept Videos
01:29Bias in Epidemiological Studies
361
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
361
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K